tiprankstipranks
Abivax SA Sponsored ADR (ABVX)
NASDAQ:ABVX
US Market

Abivax SA Sponsored ADR (ABVX) Financial Statements

24 Followers

Abivax SA Sponsored ADR Financial Overview

Abivax SA Sponsored ADR's market cap is currently ―. The company's EPS TTM is $-3.709; its P/E ratio is -3.27; Abivax SA Sponsored ADR is scheduled to report earnings on September 9, 2024, and the estimated EPS forecast is $-0.79. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Dec 22
Income Statement-
Total Revenue-€ 688.00M--
Gross Profit-€ 688.00M--
EBIT----
EBITDA----
Net Income Common Stockholders-€ -77.00M--
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 251.94M€ 244.00M€ 114.38M€ 26.95M
Total Assets€ 327.06M€ 6.89B€ 171.08M€ 75.54M
Total Debt€ 55.47M€ 2.83B€ 14.72M€ 19.83M
Net Debt€ -196.48M€ 2.59B€ -99.66M€ -7.12M
Total Liabilities€ 131.05M€ 4.53B€ 90.59M€ 68.36M
Stockholders Equity€ 196.01M€ 2.28B€ 80.49M€ 7.19M
Cash Flow-
Free Cash Flow-€ 141.00M--
Operating Cash Flow-€ 181.00M--
Investing Cash Flow-€ -70.00M--
Financing Cash Flow-€ -62.00M--
Currency in EUR

Abivax SA Sponsored ADR Earnings and Revenue History

Abivax SA Sponsored ADR Debt to Assets

Abivax SA Sponsored ADR Cash Flow

Abivax SA Sponsored ADR Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis